Nautilus endovascular device
DevicePatients will be treated with the Nautilus Endovascular device followed by treatment follow up for up to 6 months
NCT Number: NCT04963933
An aneurysm is a bulge in a blood vessel caused by a weakness in the blood vessel wall, usually where it branches. As blood passes through the weakened blood vessel, the blood pressure causes a small area to bulge outwards like a balloon. Most brain aneurysms only cause noticeable symptoms if they burst (rupture). This leads to an extremely serious condition known as a subarachnoid hemorrhage, where bleeding caused by the ruptured aneurysm can cause extensive brain damage and symptoms.
The study aims to evaluate the safety and effectiveness of a medical device to treat brain aneurysms.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
St. Ivan Rilski University hospital, Sofia, Bulgaria
Patients will be treated with the Nautilus, then will be followed up for up to 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be treated with the Nautilus Endovascular device followed by treatment follow up for up to 6 months
Time frame: 3-6 months
The rate of participants experiencing death or stroke in treated vascular territory measured using the NIH stroke scale within 3- 6 months follow-up
Time frame: 3-6 months
Rate of stable, successful aneurysm occlusion measured using the Raymond Roy Occlusion Classification at 3-6 months follow-up
EndoStream Medical
Industry
Treatment of Ruptured and Unruptured Wide-Neck Aneurysms With Nautilus™ Device Assisted Occlusion (TORNADO)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05774782
Aneurysm, Brain Diseases
Beijing, China
View Trial DetailsNCT05945563
Aneurysm, Brain Diseases
Dallas, Texas, United States
View Trial DetailsNCT01655784
Aneurysm, Brain Diseases
Fresno, California, United States
View Trial DetailsNCT02700607
Aneurysm, Brain Diseases
View Trial Details